Compare Enzyme (MLN) vs Nibiru Chain (NIBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Nibiru Chain — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Nibiru Chain trades at Rp35.29 (market cap Rp55,17M, Rp4,69M 24h volume). The key difference: Enzyme is far larger — about 2.4× Nibiru Chain's market cap, and Nibiru Chain's supply is capped (954M / 1,5B NIBI (64%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Nibiru Chain for 7 Days on average.
| MLN | NIBI | |
|---|---|---|
Market Cap | Rp134,13M | Rp55,17M |
Volume (24h) | Rp104,56M | Rp4,69M |
Circulating Supply | 3,3M MLN | 954M / 1,5B NIBI (64%) |
Typical Hold Time | 29 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Nibiru Chain (NIBI) presents a modest market cap of Rp55,17M with 64% of its 1.5M token max supply in circulation. Current price data is unavailable, limiting short-term trend analysis. The 7-day average hold time suggests some holder commitment, but the absence of recent trading data and news indicates low market activity and visibility.
Overall outlook is cautious due to significant data gaps and low liquidity. The primary opportunity lies in the project's early stage if future development gains traction. Major risks include extreme volatility from low trading volume, potential liquidity crunches, and the project's reliance on future ecosystem growth to drive value.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Nibiru Chain
Nibiru Chain is a groundbreaking Layer 1 blockchain and smart contract ecosystem that offers exceptional throughput and unmatched security. Nibiru strives to be the most developer-friendly and user-friendly smart contract ecosystem, leading the way toward mainstream Web3 adoption. It achieves this by innovating at every layer of the technology stack, including dApp development, infrastructure, consensus mechanisms, a comprehensive developer toolkit, and value accrual.
Read more on NIBI →
